Cardiovascular function and predictors of exercise capacity in patients with colorectal cancer

Journal of the American College of Cardiology

Volumn 64, Issue 13, 2014, Pages 1310-1319

  Cramer, Larissa ^a   Hildebrandt, Bert ^a   Kung, Thomas ^a   Wichmann, Kristin ^a   Springer, Jochen ^b   Doehner, Wolfram ^a   Sandek, Anja ^a   Valentova, Miroslava ^b,c   Stojakovic, Tatjana ^d   Scharnagl, Hubert ^d   Riess, Hanno ^a   Anker, Stefan D ^a,b   Von Haehling, Stephan ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c FACULTY HOSPITAL   (Slovakia)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

cardiovascular function; colorectal cancer; exercise capacity

Indexed keywords

CARBOXY TERMINAL PRO ENDOTHELIN 1; ENDOTHELIN 1; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; BODY COMPOSITION; CARDIOVASCULAR FUNCTION; COLORECTAL CANCER; CONTROLLED STUDY; EXERCISE TOLERANCE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE VARIABILITY; HUMAN; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; PHYSICAL CAPACITY; PREDICTION; AGED; CARDIOVASCULAR SYSTEM; COLORECTAL TUMOR; DYSPNEA; ECHOCARDIOGRAPHY; ERGOMETRY; EXERCISE; FATIGUE; HEART LEFT VENTRICLE FUNCTION; HEART RATE; MIDDLE AGED; PATHOPHYSIOLOGY; PHOTON ABSORPTIOMETRY; PHYSIOLOGY; PROSPECTIVE STUDY;

CARDIOVASCULAR FUNCTION; COLORECTAL CANCER; EXERCISE CAPACITY;

ABSORPTIOMETRY, PHOTON; AGED; ANTINEOPLASTIC AGENTS; BODY COMPOSITION; CARDIOVASCULAR SYSTEM; COLORECTAL NEOPLASMS; DYSPNEA; ECHOCARDIOGRAPHY; ERGOMETRY; EXERCISE; EXERCISE TOLERANCE; FATIGUE; FEMALE; HEART FAILURE; HEART RATE; HUMANS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PROSPECTIVE STUDIES; VENTRICULAR FUNCTION, LEFT;

EID: 84908284282     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.07.948     Document Type: Article

References (46)

1. Stuart BW, Kleihues P. World Cancer Report 2003. Available at: http://www.scribd.com/doc/2350813/World-Cancer-Report-2003-Stuart-e-Kleihues-WHO-e-IARC. Accessed August 15, 2012.
2. L.I. Wagner, and D. Cella Fatigue and cancer: causes, prevalence and treatment approaches Br J Cancer 5 2004 822 828
3. M.J. Velthuis, A.M. May, and R.A. Koppejan-Rensenbrink Physical Activity during Cancer Treatment (PACT) Study: design of a randomised clinical trial BMC Cancer 10 2010 272 280
4. W. Doehner, S. von Haehling, S.D. Anker, and M. Lainscak Neurohormonal activation and inflammation in chronic cardiopulmonary disease: a brief systematic review Wien Klin Wochenschr 9-10 2009 293 296
5. N.G. Morgenthaler, J. Struck, C. Alonso, and A. Bergmann Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay Clin Chem 10 2005 1823 1829
6. E.A. Jankowska, G.S. Filippatos, and S. von Haehling Identification of chronic heart failure patients with a high 12-month mortality risk using biomarkers including plasma C-terminal pro-endothelin-1 PLoS ONE 1 2011 e14506
7. N.G. Morgenthaler, J. Struck, B. Thomas, and A. Bergmann Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma Clin Chem 1 2004 234 236
8. N.G. Morgenthaler, J. Struck, C. Alonso, and A. Bergmann Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin Clin Chem 1 2006 112 119
9. R.M. Lang, M. Bierig, and R.B. Devereux Recommendations for chamber quantification: a Report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology J Am Soc Echocardiogr 12 2005 1440 1463
10. Vanderlei LC, Pastre CM, Hoshi RA, Carvalho TD, Godoy MF. Basic notions of heart rate variability and its clinical applicability. Rev Bras Cir Cardiovasc 2009;2:205-217.
11. A. Stâhle, R. Nordlander, and L. Bergfeldt Aerobic group training improves exercise capacity and heart rate variability in elderly patients with a recent coronary event. A randomized controlled study Eur Heart J 22 1999 1638 1646
12. P.E. Vardas, E.M. Kanoupakis, G.E. Kochiadakis, E.N. Simantirakis, M.E. Marketou, and G.I. Chlouverakis Effects of long-term digoxin therapy on heart rate variability, baroreceptor sensitivity, and exercise capacity in patients with heart failure Cardiovasc Drugs Ther 1 1998 47 55
13. F. Galetta, F. Franzoni, F.R. Femia, N. Roccella, F. Pentimone, and G. Santoro Lifelong physical training prevents the age-related impairment of heart rate variability and exercise capacity in elderly people J Sports Med Phys Fitness 2 2005 217 221
14. W. Banzer, K. Lucki, M. Bürklein, A. Rosenhagen, and L. Vogt (Sports medical aspects in cardiac risk stratification-heart rate variability and exercise capacity) Herzschrittmacherther Elektrophysiol 4 2006 197 204 (in German)
15. B. Mettauer, J.P. Fouillot, and E. Epailly Heart rate variability, exercise capacity, and O2 uptake kinetics in heart transplant recipients Transplant Proc 5 1998 1930 1931
16. U. Rajendra Acharya, K. Paul Joseph, N. Kannathal, C.M. Lim, and J.S. Suri Heart rate variability: a review Med Biol Eng Comput 12 2006 1031 1051
17. M. Lukaszewicz-Zając, B. Mroczko, M. Gryko, B. Kędra, and M. Szmitkowski Comparison between clinical significance of serum proinflammatory proteins (IL-6 and CRP) and classic tumor markers (CEA and CA 19-9) in gastric cancer Clin Exp Med 2 2011 89 96
18. N. Ilhan, N. Ilhan, Y. Ilhan, H. Akbulut, and M. Kucuksu C-reactive protein, procalcitonin, interleukin-6, vascular endothelial growth factor and oxidative metabolites in diagnosis of infection and staging in patients with gastric cancer World J Gastroenterol 8 2004 1115 1120
19. F.L. Marasciulo, M. Montagnani, and M.A. Potenza Endothelin-1: the yin and yang on vascular function Curr Med Chem 14 2006 1655 1665
20. F. Brunner, C. Brás-Silva, A.S. Cerdeira, and A.F. Leite-Moreira Cardiovascular endothelins: essential regulators of cardiovascular homeostasis Pharmacol Ther 2 2006 508 531
21. F. Rodríguez-Pascual, O. Busnadiego, D. Lagares, and S. Lamas Role of endothelin in the cardiovascular system Pharmacol Res 6 2011 463 472
22. E. Senkus, and J. Jassem Cardiovascular effects of systemic cancer treatment Cancer Treat Rev 4 2011 300 311
23. L. Balloni, C. Porta, and S. Rossi Left ventricular function in colon cancer patients receiving adjuvant fluoro-folate chemotherapy: an echocardiographic study Oncol Rep 4 2000 887 890
24. N.C. Robben, A.W. Pippas, and J.O. Moore The syndrome of 5-fluorouracil cardiotoxicity. An elusive cardiopathy Cancer 2 1993 493 509
25. A.M. Grandi, G. Pinotti, and E. Morandi Noninvasive evaluation of cardiotoxicity of 5-fluorouracil and low doses of folinic acid: a one-year follow-up study Ann Oncol 7 1997 705 708
26. G.S. Filippatos, S.D. Anker, and D.T. Kremastinos Pathophysiology of peripheral muscle wasting in cardiac cachexia Curr Opin Clin Nutr Metab Care 3 2005 249 254
27. M. Rauchhaus, W. Doehner, and D.P. Francis Plasma cytokine parameters and mortality in patients with chronic heart failure Circulation 25 2000 3060 3067
28. P.J. De Raaf, S. Sleijfer, C.H.J. Lamers, A. Jager, J.W. Gratama, and C.C.D. van der Rijt Inflammation and fatigue dimensions in advanced cancer patients and cancer survivors: an explorative study Cancer 23 2012 6005 6011
29. T. Rich, P.F. Innominato, and J. Boerner Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer Clin Cancer Res 5 2005 1757 1764
30. A.J. Litterini, and D.U. Jette Exercise for managing cancer-related fatigue Phys Ther 3 2011 301 304
31. C.L. Granger, C.F. McDonald, S. Berney, C. Chao, and L. Denehy Exercise intervention to improve exercise capacity and health related quality of life for patients with non-small cell lung cancer: a systematic review Lung Cancer 2 2011 139 153
32. L.W. Jones, N.D. Eves, and B.L. Peterson Safety and feasibility of aerobic training on cardiopulmonary function and quality of life in postsurgical nonsmall cell lung cancer patients: a pilot study Cancer 12 2008 3430 3439
33. R. Staud Heart rate variability as a biomarker of fibromyalgia syndrome Fut Rheumatol 5 2008 475 483
34. J.Y. Lee, K.-J. Joo, and J.T. Kim Heart rate variability in men with erectile dysfunction Int Neurourol J 2 2011 87 91
35. R. Von Känel, R.M. Carney, S. Zhao, and M.A. Whooley Heart rate variability and biomarkers of systemic inflammation in patients with stable coronary heart disease: findings from the Heart and Soul Study Clin Res Cardiol 3 2011 241 247
36. G.R.H. Sandercock, P.D. Bromley, and D.A. Brodie Effects of exercise on heart rate variability: inferences from meta-analysis Med Sci Sports Exerc 3 2005 433 439
37. H.R. Kwon, K.W. Min, and H.J. Ahn effects of aerobic exercise vs. resistance training on endothelial function in women with type 2 diabetes mellitus Diabetes Metab J 4 2011 364 373
38. G. Malfatto, M. Facchini, L. Sala, G. Branzi, R. Bragato, and G. Leonetti Effects of cardiac rehabilitation and beta-blocker therapy on heart rate variability after first acute myocardial infarction Am J Cardiol 7 1998 834 840
39. J.L. Lin, H.L. Chan, and C.C. Du Long-term beta-blocker therapy improves autonomic nervous regulation in advanced congestive heart failure: a longitudinal heart rate variability study Am Heart J 4 Pt 1 1999 658 665
40. R. Lampert, J.R. Ickovics, C.J. Viscoli, R.I. Horwitz, and F.A. Lee Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the Beta-Blocker Heart Attack Trial Am J Cardiol 2 2003 137 142
41. K. Jansson, I. Hagerman, and R. Ostlund The effects of metoprolol and captopril on heart rate variability in patients with idiopathic dilated cardiomyopathy Clin Cardiol 6 1999 397 402
42. M.A. Broeders, P.A. Doevendans, and B.C. Bekkers Nebivolol: a third-generation beta-blocker that augments vascular nitric oxide release: endothelial beta(2)-adrenergic receptor-mediated nitric oxide production Circulation 6 2000 677 684
43. H. Mollnau, E. Schulz, and A. Daiber Nebivolol prevents vascular NOS III uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells Arterioscler Thromb Vasc Biol 4 2003 615 621
44. T. Banach, W. Kolasińska-Kloch, A. Furgała, and J. Laskiewicz The effect of the year angiotensin-converting enzyme inhibitors (ACE I) intake on circadian heart rate variability in patients with primary hypertension Folia Med Cracov 3 2001 129 140
45. V.S. Zdionchenko, K.S. Leksina, N.I. Timofeeva, G.G. Shekhian, K.M. Bagatyrova, and M.A. Mironova (Effect of angiotensin converting enzyme inhibitors on oxidative stress, endothelial function in patients with myocardial infarction) Kardiologiia 7-8 2009 32 37 (in Russian)
46. H.L. Lazar, Y. Bao, S. Rivers, T. Colton, and S.A. Bernard High tissue affinity angiotensin-converting enzyme inhibitors improve endothelial function and reduce infarct size Ann Thorac Surg 2 2001 548 554